Healthcare -
Biotechnology - NASDAQ - US
$ 21.4
3.68 %
$ 1.9 B
Market Cap
-5.26
P/E
TVTX - CAPITAL EXPENDITURES
Capital Expenditures TVTX - Travere Therapeutics, Inc.
0
LAST VALUE
41.42%
2 YEAR CAGR
14.87%
5 YEAR CAGR
7.18%
10 YEAR CAGR